HomeFloventLatest Flovent News
Posted in Flovent on 29th April 2014

Mylan Inks Two Separate Agreements
Flixotide and Flovent are approved for the treatment of asthma and had global brand sales of around $ 1.3 billion in 2013 as per IMS Health. As per the terms of the agreement, Mylan will gain marketing rights for PSX1001 and PSX1050 in the U.S., Canada, …
Read more on Zacks.com

Related Post for COPD throws challenges in the way of patients

Employers fight drug costs
Latest News Flovent
Sour cream, jalapeno calmed hands
How to Use an Albuterol Inhaler
COPD throws challenges in the way of patients
tags: , ,